Other immune checkpoints are emerging in regulating cancer progression such as the V-domain Ig suppressor of T-cell activation (VISTA) expressed in CD4+ and CD8+ T cells but also in CD68+ cells (macrophages) [133]. Here, CD8A is linked to cancer.